Voyager Therapeutics, Inc. (BMV:VYGR)

Voyager Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	74.76	71.37	68.8	98.96	117.43	104.44
Short-Term Investments	161.26	195.32	162.07	19.89	15.11	76.7
Cash & Short-Term Investments	236.02	266.68	230.88	118.85	132.54	181.14
Cash Growth	-40.93%	15.51%	94.26%	-10.33%	-26.83%	-35.66%
Accounts Receivable	2.11	2.18	83.49	0.26	0.73	8.01
Other Receivables	-	2.31	0.96	0.38	0.02	0.1
Receivables	2.11	4.49	84.46	0.64	0.75	8.11
Prepaid Expenses	7.08	0.43	0.61	0.7	1.36	1.46
Other Current Assets	-	5.21	3.75	4.32	2.05	7.07
Total Current Assets	245.21	276.81	319.68	124.5	136.7	197.77
Property, Plant & Equipment	46.06	47.66	30	33.34	55.38	61.5
Long-Term Investments	59.1	65.7	-	-	-	-
Other Long-Term Assets	2.87	2.87	1.59	1.52	1.78	2.32
Total Assets	353.24	393.05	351.28	159.36	193.86	261.58
Accounts Payable	2.63	4	1.6	2.57	0.57	0.63
Accrued Expenses	9.05	14.17	16.82	7.82	10.95	14.21
Current Portion of Leases	7.43	7.23	3.2	2.83	5.57	4.2
Current Unearned Revenue	21.1	24.39	42.88	59.38	33.89	7.73
Total Current Liabilities	40.21	49.79	64.51	72.59	50.98	26.77
Long-Term Leases	34.57	36.5	17.09	20.29	38.61	43.41
Long-Term Unearned Revenue	4.76	6	32.36	6.45	8.21	36.09
Other Long-Term Liabilities	1	1	1	1	1	1
Total Liabilities	80.54	93.29	114.96	100.34	98.8	107.26
Common Stock	0.06	0.06	0.04	0.04	0.04	0.04
Additional Paid-In Capital	630.05	626.3	497.51	452.71	442.26	430.32
Retained Earnings	-357.21	-326.18	-261.18	-393.51	-347.1	-275.91
Comprehensive Income & Other	-0.2	-0.41	-0.05	-0.22	-0.14	-0.13
Total Common Equity	272.7	299.76	236.32	59.02	95.06	154.32
Shareholders' Equity	272.7	299.76	236.32	59.02	95.06	154.32
Total Liabilities & Equity	353.24	393.05	351.28	159.36	193.86	261.58
Total Debt	42	43.73	20.29	23.13	44.18	47.61
Net Cash (Debt)	253.13	288.66	210.58	95.72	88.36	133.53
Net Cash Growth	-28.21%	37.08%	119.99%	8.33%	-33.83%	-46.43%
Net Cash Per Share	4.37	5.01	4.72	2.50	2.35	3.58
Filing Date Shares Outstanding	55.34	55.21	54.3	43.29	38.11	37.65
Total Common Shares Outstanding	55.21	54.73	44.04	38.61	37.92	37.37
Working Capital	204.99	227.02	255.18	51.91	85.72	171
Book Value Per Share	4.94	5.48	5.37	1.53	2.51	4.13
Tangible Book Value	272.7	299.76	236.32	59.02	95.06	154.32
Tangible Book Value Per Share	4.94	5.48	5.37	1.53	2.51	4.13
Machinery	-	22.67	23.16	22.01	21.91	20.5
Construction In Progress	-	-	-	-	-	0.87
Leasehold Improvements	-	6.49	7.11	12.55	15.7	15.47

Source: S&P Global Market Intelligence. Standard template. Financial Sources.